Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P000058/S098

INFUSE Bone Graft/LT-Cage Lumbar Tapered Fusion Device

MEDTRONIC SOFAMOR DANEK USA, INC. · Decision date Mar 19, 2026

FDA DECISIONP000058/S098

What did the FDA decide?

FDA records P000058/S098 as a supplement to PMA P000058, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Mar 19, 2026.

FDA approval order statement

addition of an alternate testing facility and relocation of relevant laboratories to a new building
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Orthopedic
Decision date
Mar 19, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P000058/S098
Regulatory pathway
PMA supplement
Product code
NEK
Decision code
OK30
Decision date
Mar 19, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Filler, recombinant human bone morphogenetic protein, collagen scaffold with metal prosthesis, osteoinduction.

Product code
NEK
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P000058/S098 received

    Application receipt date recorded by FDA.

  2. P000058/S097 · Related supplement

    INFUSE Bone Graft/Medtronic Interbody Fusion Device

  3. P000058/S098 · FDA decision

    30-Day Notice

  4. P000058/S099 · Related supplement

    Infuse TM Bone Graft/Medtronic lnterbody Fusion Device

  5. P000058/S095 · Related supplement

    INFUSE BONE GRAFT/LT-CAGE LUMBAR TAPERED FUSION DEVICE

Timeline entries are records held by MedtechLedger for P000058. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P000058

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Sofamor DANEK USA, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
1800 Pyramid Pl., Memphis, TN, 38132

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records